Clozapine-associated eosinophilia with multiple systemic involvement - case report and review of literature
Introduction Due to its mood-stabilizing properties, clozapine is known for reducing symptom severity in manic episodes of treatment-resistant bipolar disorder as well as in treatment-resistant schizophrenia. However, its use may be hindered by potential adverse effects, including hematologic ones...
Main Authors: | I. Orlović, T. Sugnet, M. Peco, V. Golubić Zatezalo, H. Karlica, D. Karlović |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S092493382101289X/type/journal_article |
Similar Items
-
Multiorgan eosinophilic infiltration after initiation of clozapine therapy: a case report
by: Dorota Marchel, et al.
Published: (2017-07-01) -
Continuation with clozapine after eosinophilia: a case report
by: Yen-Cheng Ho, et al.
Published: (2017-12-01) -
Eosinophilia induced by clozapine: A report of two cases and review of the literature
by: Jitender Aneja, et al.
Published: (2015-01-01) -
Clozapine‐associated severe eosinophilia following lithium rebound neutropenia: A case report
by: Kota Kikuchi, et al.
Published: (2020-12-01) -
Clozapine-induced myocarditis: a case report and literature review
by: I. Angélico Ferreira, et al.
Published: (2022-06-01)